Uploaded March 2025 | Updated September 2026, 2 weeks ago
This second webinar aimed at presenting the draft scientific opinion, introducing the driving elements and the key chapters of the draft document, which will be under public consultation from mid-January to mid-March 2025.
In line with EFSA’s commitment to transparency and engagement with its stakeholders, and as part of the ongoing dialogue with interested parties as part of this mandate, the webinar aimed at providing a clear understanding of the key components of and rationale behind the scientific opinion. It was also an occasion for stakeholders to clarify any doubts regarding the public consultation phase.
The current subtitles have been automatically produced by YouTube. EFSA does not accept any liability for mistakes or inaccuracies resulting from the transcribing process.
Discover more about EFSA on our channels:
▪ Website: https://www.efsa.europa.eu/en
▪ Twitter: twitter.com/efsa_eu
▪ LinkedIn: linkedin.com/company/efsa
▪ Instagram: instagram.com/one_healthenv_eu
This second webinar aimed at presenting the draft scientific opinion, introducing the driving elements and the key chapters of the draft document, which will be under public consultation from mid-January to mid-March 2025.
In line with EFSA’s commitment to transparency and engagement with its stakeholders, and as part of the ongoing dialogue with interested parties as part of this mandate, the webinar aimed at providing a clear understanding of the key components of and rationale behind the scientific opinion. It was also an occasion for stakeholders to clarify any doubts regarding the public consultation phase.
The current subtitles have been automatically produced by YouTube. EFSA does not accept any liability for mistakes or inaccuracies resulting from the transcribing process.
Discover more about EFSA on our channels:
▪ Website: https://www.efsa.europa.eu/en
▪ Twitter: twitter.com/efsa_eu
▪ LinkedIn: linkedin.com/company/efsa
▪ Instagram: instagram.com/one_healthenv_eu
